|
Volumn 11, Issue 9, 2015, Pages 634-635
|
Protein degradation: Prime time for PROTACs
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CELL PROTEIN;
FK 506 BINDING PROTEIN;
HYDROXYPROLINE;
PROTACS PROTEIN;
PROTEASOME;
PROTEIN SERINE THREONINE KINASE;
UBIQUITIN PROTEIN LIGASE;
UNCLASSIFIED DRUG;
MOLECULAR LIBRARY;
PROTEIN BINDING;
UBIQUITINATED PROTEIN;
BIOAVAILABILITY;
CELL CULTURE;
CELL LYSATE;
CELLS BY BODY ANATOMY;
DRUG ABSORPTION;
DRUG HALF LIFE;
EC50;
MOLECULAR WEIGHT;
MOLECULE;
NOTE;
ONCOGENE C MYC;
PERFORMANCE;
PRIORITY JOURNAL;
PROMOTER REGION;
PROTEIN DEGRADATION;
PROTEIN FUNCTION;
PROTEOMICS;
UBIQUITINATION;
ANIMAL;
BINDING SITE;
CHEMISTRY;
DRUG EFFECTS;
HUMAN;
METABOLISM;
MOLECULAR LIBRARY;
MOLECULARLY TARGETED THERAPY;
PHARMACOLOGY;
STRUCTURE ACTIVITY RELATION;
SYNTHESIS;
ANIMALS;
BINDING SITES;
HUMANS;
MOLECULAR TARGETED THERAPY;
PROTEASOME ENDOPEPTIDASE COMPLEX;
PROTEIN BINDING;
PROTEOLYSIS;
SMALL MOLECULE LIBRARIES;
STRUCTURE-ACTIVITY RELATIONSHIP;
UBIQUITIN-PROTEIN LIGASES;
UBIQUITINATED PROTEINS;
UBIQUITINATION;
|
EID: 84939552495
PISSN: 15524450
EISSN: 15524469
Source Type: Journal
DOI: 10.1038/nchembio.1887 Document Type: Note |
Times cited : (136)
|
References (13)
|